BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17259560)

  • 1. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the molecular basis for tumour hypoxia.
    Carroll VA; Ashcroft M
    Expert Rev Mol Med; 2005 Apr; 7(6):1-16. PubMed ID: 15831177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hypoxia cell signaling for cancer therapy.
    Melillo G
    Cancer Metastasis Rev; 2007 Jun; 26(2):341-52. PubMed ID: 17415529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis.
    Lum JJ; Bui T; Gruber M; Gordan JD; DeBerardinis RJ; Covello KL; Simon MC; Thompson CB
    Genes Dev; 2007 May; 21(9):1037-49. PubMed ID: 17437992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting hypoxia-inducible factor 1 for cancer therapy.
    Melillo G
    Mol Cancer Res; 2006 Sep; 4(9):601-5. PubMed ID: 16940159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1alpha in oral cancer.
    Brennan PA; Mackenzie N; Quintero M
    J Oral Pathol Med; 2005 Aug; 34(7):385-9. PubMed ID: 16011605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
    Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
    Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression.
    O'Donnell JL; Joyce MR; Shannon AM; Harmey J; Geraghty J; Bouchier-Hayes D
    Cancer Treat Rev; 2006 Oct; 32(6):407-16. PubMed ID: 16889900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent agents targeting HIF-1α for cancer therapy.
    Hu Y; Liu J; Huang H
    J Cell Biochem; 2013 Mar; 114(3):498-509. PubMed ID: 22961911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HIF-1 for cancer therapy.
    Semenza GL
    Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species and HIF-1 signalling in cancer.
    Galanis A; Pappa A; Giannakakis A; Lanitis E; Dangaj D; Sandaltzopoulos R
    Cancer Lett; 2008 Jul; 266(1):12-20. PubMed ID: 18378391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoxia and angiogenesis].
    Simon JM
    Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1 (HIF-1) in cancer.
    Quintero M; Mackenzie N; Brennan PA
    Eur J Surg Oncol; 2004 Jun; 30(5):465-8. PubMed ID: 15135470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the hypoxia-inducible factor in cancer and ischemic disease.
    Brahimi-Horn MC; Pouysségur J
    Biochem Pharmacol; 2007 Feb; 73(3):450-7. PubMed ID: 17101119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.